Results 141 to 150 of about 2,327,860 (219)

Clinical safety and possible efficacy of tirofiban in combination with intravenous thrombolysis by recombinant tissue plasminogen activator for early treatment of capsular warning syndrome (CWS). [PDF]

Front Neurosci, 2022
Liu Y, Li S, Hao D, Zhang Z, Yi Y, Fang J, Lin W, Zhang M.   +7 more
europepmc   +1 more source

Thrombolytic therapy efficacy in cardiopulmonary resuscitation: Investigating the effect of recombinant tissue plasminogen activator (Review). [PDF]

Mol Med Rep
Zhang W, Pan Y, Ding J, Xu D, Wang W.
europepmc   +1 more source

One-Year Outcomes After Intravenous Recombinant Tissue Plasminogen Activator for Ischemic Stroke: A Real-World Study. [PDF]

CNS Neurosci Ther
Xue R, Gong X, Huang Y, Zhong W, Jin H, Chen Z, Chen Y, Yan S, Hu H, Yuan C, Lou M.   +10 more
europepmc   +1 more source

Usefulness of carotid duplex ultrasonography in predicting residual large-vessel occlusions after intravenous recombinant tissue plasminogen activator therapy in patients with acute ischemic stroke. [PDF]

J Med Ultrason (2001), 2023
Kaburagi K, Shimizu T, Hagiwara Y, Fukano T, Shibata S, Hoshino M, Sasaki N, Akiyama H, Hasegawa Y, Yamano Y.   +9 more
europepmc   +1 more source

Predictive value of serum homocysteine and potassium ion for short-term prognosis of patients with acute cerebral infarction following intravenous thrombolysis with recombinant tissue plasminogen activator. [PDF]

Thromb J
Pang L, Sun Y, He M, Xu B.
europepmc   +1 more source

Correction: Usefulness of carotid duplex ultrasonography in predicting residual large-vessel occlusions after intravenous recombinant tissue plasminogen activator therapy in patients with acute ischemic stroke. [PDF]

J Med Ultrason (2001)
Kaburagi K, Shimizu T, Hagiwara Y, Fukano T, Shibata S, Hoshino M, Sasaki N, Akiyama H, Hasegawa Y, Yamano Y.   +9 more
europepmc   +1 more source

Use of recombinant tissue plasminogen activator (rTPA) for treatment of fibrin in the anterior chamber of the horse. [PDF]

Vet Med Sci
Pereira R, Bowen M, Rapezzano G, Redpath A, Pratt S, Hallowell G.   +5 more
europepmc   +1 more source

The efficacy of recombinant tissue plasminogen activator in severe post-operative fibrinous reaction after uneventful phacoemulsification - a case series and review. [PDF]

Rom J Ophthalmol, 2022
Ibramsah AB, Cheong AI, Wan Muda WN, Ibrahim M.   +3 more
europepmc   +1 more source

Pharmacokinetics and pharmacodynamics of low doses of recombinant tissue plasminogen activator to establish a model for biosimilarity comparisons. [PDF]

Res Pract Thromb Haemost
Derhaschnig U, Buchtele N, Steiner MM, Drucker C, Firbas C, Schörgenhofer C, Gelbenegger G, König F, Jilma B, Kovacevic Miljevic KD.   +9 more
europepmc   +1 more source

Might life-threatening acute pulmonary edema occur after using recombinant tissue plasminogen activator? A case report. [PDF]

BMC Neurol, 2021
Chen XB, Qu D, Zhang Q, Yue X, Qiao DF.
europepmc   +1 more source